California State Teachers Retirement System (CalSTRS)’s LogicBio Therapeutics, Inc. Common Stock LOGC Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio LOGC Stock Details LOGC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-24,804	Closed	-$181K	–	3319
2021 Q1	$181K	Hold	24,804	–	–	﹤0.01%	2930
2020 Q4	$189K	Buy	24,804 +6,661	+37%	+$44.6K	﹤0.01%	2858
2020 Q3	$165K	Hold	18,143	–	–	﹤0.01%	2810
2020 Q2	$153K	Buy	18,143 +5,277	+41%	+$34.7K	﹤0.01%	2836
2020 Q1	$64K	Buy	12,866 +148	+1%	+$1.15K	﹤0.01%	2890
2019 Q4	$92K	Hold	12,718	–	–	﹤0.01%	2933
2019 Q3	$137K	Hold	12,718	–	–	﹤0.01%	2898
2019 Q2	$165K	Hold	12,718	–	–	﹤0.01%	2910
2019 Q1	$126K	Sell	12,718 -1,993	-14%	-$18.6K	﹤0.01%	2870
2018 Q4	$153K	Buy	+14,711	New	+$178K	﹤0.01%	2845

Other funds holding LOGC

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

LPC

Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

PVI

Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s LOGC Position: Q2 2021 in Review

California State Teachers Retirement System (CalSTRS) sold out of LogicBio Therapeutics, Inc. Common Stock (LOGC) in Q2 2021, closing a stake of 24,804 shares — an estimated $181K sold.

California State Teachers Retirement System (CalSTRS) first reported a position in LOGC in Q4 2018 and held it in 10 quarters. The position peaked at $189K in Q4 2020. 63 funds tracked by Wall St. Rank hold LOGC as of Q2 2021.

California State Teachers Retirement System (CalSTRS) reported no remaining LogicBio Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
California State Teachers Retirement System (CalSTRS) sold 24,804 LogicBio Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $181K.
California State Teachers Retirement System (CalSTRS) first reported a position in LogicBio Therapeutics, Inc. Common Stock in Q4 2018 and held it in 10 quarters.
California State Teachers Retirement System (CalSTRS)'s LogicBio Therapeutics, Inc. Common Stock position peaked at $189K in Q4 2020.
63 funds tracked by Wall St. Rank held LogicBio Therapeutics, Inc. Common Stock as of Q2 2021.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2021, filed 16 Aug 2021.